Romidab XR 500 mg, 750 mg XR TABLETS
PDF Leaflet Revision Date: 4 March 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of type 2 diabetes mellitus in adults.
Dosage (summary)
Starting dose: 500 mg once daily; max: 2000 mg once daily with evening meal.
Special Populations
- Elderly
- Renal impairment
Pregnancy & Breastfeeding
Not recommended during pregnancy; no data on lactation safety.
Key Drug Interactions
- Alcohol
- Iodinated contrast media
- Sulphonylureas
- Cimetidine
Contraindications
- Hypersensitivity to metformin
- Diabetic ketoacidosis
- Renal failure
- Hepatic insufficiency
Common side effects
- Nausea
- Diarrhea
- Abdominal pain
- Lactic acidosis
Counselling Points
- Take with food
- Avoid alcohol
- Monitor blood glucose regularly
Serious warnings
- Risk of lactic acidosis
- Monitor renal function regularly
Important Disclaimer
The Romidab XR 500 mg, 750 mg XR TABLETS professional information leaflet below is the property of Aurogen Sa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
